Akcie v oběhu společnosti Kazia Therapeutics
Jaká je hodnota metriky Akcie v oběhu společnosti Kazia Therapeutics?
Hodnota metriky Akcie v oběhu společnosti Kazia Therapeutics Limited je 116.518M 88.25%
Jaká je definice metriky Akcie v oběhu?
Akce v oběhu (Shares float) je podíl akcií společnosti vlastněných veřejnými investory vůči zablokovaným akcím (nejsou volně v oběhu).
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Akcie v oběhu společností v sektoru Health Care sektor na ASX ve srovnání se společností Kazia Therapeutics
Čemu se věnuje společnost Kazia Therapeutics?
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.
Firmy s metrikou akcie v oběhu podobnou společnosti Kazia Therapeutics
- Hodnota metriky Akcie v oběhu společnosti CMC Metals je 116.280M 113.77%
- Hodnota metriky Akcie v oběhu společnosti Angkor Resources je 116.362M 75.05%
- Hodnota metriky Akcie v oběhu společnosti Generex Biotechnology je 116.432M 98.30%
- Hodnota metriky Akcie v oběhu společnosti Coromandel International je 116.462M 39.68%
- Hodnota metriky Akcie v oběhu společnosti Leucrotta Exploration je 116.483M 47.04%
- Hodnota metriky Akcie v oběhu společnosti Tower Resources je 116.501M 89.71%
- Hodnota metriky Akcie v oběhu společnosti Kazia Therapeutics je 116.518M 88.25%
- Hodnota metriky Akcie v oběhu společnosti Broadridge Solutions je 116.518M 99.80%
- Hodnota metriky Akcie v oběhu společnosti Bajaj Auto je 116.563M 40.28%
- Hodnota metriky Akcie v oběhu společnosti Capital Power je 116.585M 99.77%
- Hodnota metriky Akcie v oběhu společnosti Northern Graphite je 116.627M 96.18%
- Hodnota metriky Akcie v oběhu společnosti the Rubicon Project je 116.672M 88.51%
- Hodnota metriky Akcie v oběhu společnosti Albemarle je 116.698M 109.88%